Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 2
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Re-examination of MAGE-A3 as a T-cell Therapeutic Target.
Martin AD, Wang X, Sandberg ML, Negri KR, Wu ML, Toledo Warshaviak D, Gabrelow GB, McElvain ME, Lee B, Daris ME, Xu H, Kamb A. Martin AD, et al. Among authors: daris me. J Immunother. 2021 Apr 1;44(3):95-105. doi: 10.1097/CJI.0000000000000348. J Immunother. 2021. PMID: 33284140 Free PMC article.
Engineered T cells directed at tumors with defined allelic loss.
Hamburger AE, DiAndreth B, Cui J, Daris ME, Munguia ML, Deshmukh K, Mock JY, Asuelime GE, Lim ED, Kreke MR, Tokatlian T, Kamb A. Hamburger AE, et al. Among authors: daris me. Mol Immunol. 2020 Dec;128:298-310. doi: 10.1016/j.molimm.2020.09.012. Epub 2020 Oct 1. Mol Immunol. 2020. PMID: 33012527 Free article.
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers.
Wang X, Sandberg ML, Martin AD, Negri KR, Gabrelow GB, Nampe DP, Wu ML, McElvain ME, Toledo Warshaviak D, Lee WH, Oh J, Daris ME, Chai F, Yao C, Furney J, Pigott C, Kamb A, Xu H. Wang X, et al. Among authors: daris me. J Immunother. 2021 Oct 1;44(8):292-306. doi: 10.1097/CJI.0000000000000386. J Immunother. 2021. PMID: 34432728 Free PMC article.